At the time, the interferon was NOT pegylated, and
both interferon and ribavirin
were given via shots. The chance of cure for genotype 1 was also extremely low. Now, about 10 years later, we have next-generation interferon, oral ribavirin, and DAAs to greatly increase the chance of SVR to >80%, plus a whole host of extremely viable studies.